...
首页> 外文期刊>British Medical Bulletin >Platelet-rich plasma in the conservative treatment of painful tendinopathf: a systematic rewlew and meta-analysis of controlled studies
【24h】

Platelet-rich plasma in the conservative treatment of painful tendinopathf: a systematic rewlew and meta-analysis of controlled studies

机译:保守治疗疼痛肌腱病的富血小板血浆:对照研究的系统总结和荟萃分析

获取原文
获取原文并翻译 | 示例
           

摘要

Backgroynd: Platelet-rich plasma (PRP) seeks to meet the multifaceted demand of degenerated tendons providing several molecules capable of boosting healing.Areas timely for developing research: PRP is used for managing tendtnopa-thy, but its efficacy is controversial.Sources of data: Electronic databases were searched for clinical studies assessing PRP efficacy. Methodological quality was evaluated using the methods described in the Cochrane Handbook for systematic reviews.Areas of agreement: Thirteen prospective controlled studies, comprising 886 patients and diverse tendons were included; 53,8% of studies used identical PRP protocol.Areas of controwersy: Sources of heterogeneity included different comparators, outcome scores, follow-up periods and diverse injection protocols, but not PRP formulation perse.Growing points: Pooling pain outcomes over time and across different tendons showed that L-PRP injections ameliorated pain in the intermediate-long term compared with control interventions, weighted mean difference (95% Cl): 3 months, -0.61 (-0.97, -0.25); 1 year, -1.56 (-2.27, -0.83). However, these findings cannot be applied to the management of individual patients given low power and precision. Research: Further studies circumventing heterogeneity are needed to reach firm conclusions. Available evidence can help to overcome hurdlesjo future clinical research and bring forward PRP therapies.
机译:Backgroynd:富含血小板的血浆(PRP)旨在满足退化肌腱的多方面需求,提供能够促进愈合的多种分子。需要及时开展研究的领域:PRP用于治疗肌腱炎,但其疗效尚有争议。 :在电子数据库中搜索了评估PRP疗效的临床研究。方法学质量使用Cochrane手册中描述的方法进行系统评价。共识领域:包括13项前瞻性对照研究,其中包括886名患者和不同的肌腱。 53.8%的研究使用相同的PRP方案。争议领域:异质性来源包括不同的比较物,结果评分,随访期和不同的注射方案,但不包括PRP制剂本身。不同的肌腱显示,与对照组相比,L-PRP注射可减轻中长期疼痛,加权平均差异(95%Cl):3个月,-0.61(-0.97,-0.25); 1年,-1.56(-2.27,-0.83)。但是,由于功率和精度低,这些发现不能应用于个别患者的治疗。研究:需要进一步的研究来规避异质性以得出确定的结论。现有证据可以帮助克服hurdlesjo未来的临床研究并提出PRP疗法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号